Antisense approaches for the treatment of cancer (Q34063261)

30 July 2017

1 reference

title

Antisense approaches for the treatment of cancer (English)

1 reference

30 July 2017

Monia BP

1

1 reference

30 July 2017

Holmlund J

series ordinal

2

1 reference

30 July 2017

Dorr FA

series ordinal

3

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

18

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

635-650

1 reference

Molecular themes in oncogenesis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Chromosomal translocations in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Oncogenes and tumor suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Progress in antisense oligonucleotide therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Viral myb oncogene encodes a sequence-specific DNA-binding activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Avian myeloblastosis virus and E26 virus oncogene products are nuclear proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Subcellular localization of proteins encoded by oncogenes of avian myeloblastosis virus and avian leukemia virus E26 and by the chicken c-myb gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Cytogenetics of human malignant melanoma and premalignant lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Activation of the MAP kinase pathway by the protein kinase raf

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

The ins and outs of Raf kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

A role for c-Raf kinase and Ha-Ras in cytokine-mediated induction of cell adhesion molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Overproduction of protein kinase C causes disordered growth control in rat fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Identification and Characterization of Second-Generation Antisense Oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

The molecular genetics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

Oncogene amplification in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032830

10.3109/07357900009032830

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference